Page last updated: 2024-10-16

aminolevulinic acid and Carcinoma, Verrucous

aminolevulinic acid has been researched along with Carcinoma, Verrucous in 7 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Carcinoma, Verrucous: A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
"Our recent studies showed that a new topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) protocol using a light-emitting diode (LED) light source is an effective and successful treatment modality for five cases of oral verrucous hyperplasia (OVH) and one case of verrucous carcinoma."7.73Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. ( Chen, HM; Chiang, CP; Tsai, T; Tu, PC; Yeh, CY; Yu, CH, 2005)
"Our previous studies showed that oral verrucous hyperplasia (OVH) lesions can be successfully treated with a topical 5-aminolevulinic acid-mediated photodynamic therapy (topical ALA-PDT) protocol using a 635-nm light-emitting diode light source."3.74Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion. ( Chen, HM; Cheng, SJ; Chiang, CP; Hung, HY; Tsai, T; Yu, CH, 2008)
"Our recent studies showed that a new topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) protocol using a light-emitting diode (LED) light source is an effective and successful treatment modality for five cases of oral verrucous hyperplasia (OVH) and one case of verrucous carcinoma."3.73Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. ( Chen, HM; Chiang, CP; Tsai, T; Tu, PC; Yeh, CY; Yu, CH, 2005)
"Our previous study showed successful treatment of a large oral verrucous hyperplasia (OVH) with topical 5-aminolevulinic acid-mediated photodynamic therapy combined with cryotherapy (ALA-PDT)."1.40Successful treatment of oral verrucous hyperplasia with photodynamic therapy combined with cryotherapy--report of 3 cases. ( Chang, YC; Yu, CH, 2014)
"Cutaneous verrucous carcinoma is a low-grade and well-differentiated variant of squamous cell carcinoma."1.34Photodynamic therapy for cutaneous verrucous carcinoma. ( Nikkels, AF; Piérard, GE; Quatresooz, P; Thirion, L, 2007)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, X1
Zhang, J1
Tan, L1
Wang, W1
Song, Y1
Wang, H1
Zhang, X1
Kou, H1
Lu, Y1
Chang, YC1
Yu, CH3
Chen, HM4
Cheng, SJ2
Chiang, CP4
Chen, CT1
Yang, H1
Lee, MI1
Kuo, MY1
Kuo, YS1
Wang, YP1
Tsai, T3
Tu, PC1
Yeh, CY1
Nikkels, AF1
Thirion, L1
Quatresooz, P1
Piérard, GE1
Hung, HY1

Other Studies

7 other studies available for aminolevulinic acid and Carcinoma, Verrucous

ArticleYear
Treatment of verrucous carcinoma in penis with topical aminolevulinic acid photodynamic therapy: An effective and safe treatment method.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 24

    Topics: Adult; Aminolevulinic Acid; Carcinoma, Verrucous; Humans; Male; Middle Aged; Neoplasm Recurrence, Lo

2018
Successful treatment of oral verrucous hyperplasia with photodynamic therapy combined with cryotherapy--report of 3 cases.
    Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:2

    Topics: Adult; Aminolevulinic Acid; Carcinoma, Verrucous; Combined Modality Therapy; Cryotherapy; Humans; Ma

2014
Topical photodynamic therapy is the first-line treatment of choice for oral erythroleukoplakia and oral verrucous hyperplasia.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:7

    Topics: Aminolevulinic Acid; Carcinoma, Verrucous; Humans; Hyperplasia; Leukoplakia, Oral; Mouth; Photochemo

2015
Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2005, Volume: 34, Issue:4

    Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Verrucous; Dose Fractionation, Radiation; F

2005
Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Lasers in surgery and medicine, 2005, Volume: 37, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Carcinoma, Verrucous; Drug Administration

2005
Photodynamic therapy for cutaneous verrucous carcinoma.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:3

    Topics: Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Verrucous; Chronic Disease; Drug Administration S

2007
Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion.
    Oral oncology, 2008, Volume: 44, Issue:6

    Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Carcinoma, Verrucous; Female; Humans; Hyp

2008